How should an acute facial rash with burning and peeling that develops during an ear infection be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Acute Facial Rash with Burning and Peeling During Ear Infection

This presentation most likely represents allergic contact dermatitis to otic medications, particularly neomycin-containing ear drops, which causes reactions in 5-15% of patients with external ear infections. 1

Immediate Evaluation Steps

Look for these specific clinical features:

  • Maculopapular or eczematous eruption on the conchal bowl and ear canal
  • Erythematous streak extending down the pinna where drops contact the auricular skin
  • Erythema, edema, scaling, itching, and pain on facial areas contacted by medication
  • Timing: symptoms appearing or worsening after starting otic drops (typically 10-14 days for initial sensitization, but faster with re-exposure) 1

Critical differential diagnoses to exclude:

  1. Herpes zoster oticus (Ramsay Hunt syndrome) - Look for vesicles on the external ear canal and posterior auricle, severe otalgia, facial paralysis, loss of taste, decreased lacrimation. This requires immediate systemic antiviral therapy and steroids. 1, 2

  2. Staphylococcal scalded skin syndrome - Blanching erythematous macules with well-demarcated borders, scaling, and skin denudation. More common in young children but can occur at any age. 3

  3. Underlying dermatoses - Eczema, seborrheic dermatitis, or psoriasis that may have been exacerbated by the ear infection or its treatment 1

Management Algorithm

Step 1: Stop the Offending Agent

Immediately discontinue all otic preparations, especially if they contain:

  • Neomycin (most common culprit: 5-15% reaction rate)
  • Other topical antimicrobials (bacitracin, quinolones, polymyxin B)
  • Preservatives (propylene glycol, thimerosal, benzalkonium chloride) 1

Step 2: Treat the Contact Dermatitis

Apply topical corticosteroid to affected facial areas:

  • Use potent topical corticosteroid (class II or III preparation based on severity and location)
  • Alternative: Calcineurin inhibitors (tacrolimus 0.1% ointment or pimecrolimus 1% cream) for facial involvement 1, 4

Step 3: Address the Underlying Ear Infection

Switch to a non-sensitizing otic preparation:

  • Use antiseptic or acidifying drops (acetic acid-based preparations)
  • If bacterial infection requires antibiotic coverage, select fluoroquinolone drops (lower sensitization rates than neomycin)
  • Ensure adequate aural toilet (debris removal) to enhance drug delivery 1

Step 4: Supportive Care

  • Apply emollients to affected facial skin
  • Avoid further trauma or irritation to the area
  • Keep the ear canal dry during treatment 1

Critical Pitfalls to Avoid

Do not continue otic drops "to complete the course" if contact dermatitis is suspected - this will worsen the reaction and extend beyond the ear to involve neck and facial skin wherever contact occurs 1

Do not use neomycin-containing preparations in patients with chronic or recurrent ear infections, as 13% of normal volunteers are hypersensitive to neomycin on patch testing 1

Do not miss Ramsay Hunt syndrome - if vesicles are present with facial weakness, this is a medical emergency requiring antiviral therapy within 72 hours for optimal outcomes 1

Follow-Up Considerations

If symptoms persist despite stopping the offending agent and treating with topical steroids:

  • Consider patch testing to identify specific allergen (though routine testing is not recommended) 1
  • Reassess for alternative diagnoses including fungal overgrowth, resistant bacteria, or underlying dermatologic conditions 1
  • Culture the ear canal if infection persists to guide targeted therapy 1

Document the drug allergy prominently in the medical record and educate the patient to avoid neomycin-containing products in the future, as subsequent exposures will trigger more pronounced inflammatory responses 1

References

Guideline

clinical practice guideline: acute otitis externa.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

Research

[Herpes zoster oticus].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.